Tepotinib Hepatic Impairment Trial
Clinical trial NCT03546608 · COMPLETED
Trial details
- NCT number
- NCT03546608
- Sponsor
- EMD Serono Research & Development Institute, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-13
- Primary completion
- 2019-02-05
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.